Last reviewed · How we verify
NCT03600298
Simulation Training of Closed-Loop Communication (CLC)
NA trial testing Simulation in Pediatric Intensive Care Unit in 15 participants. Completed in 25 January 2018.
31 December 2017
Quick facts
| Lead sponsor | Insel Gruppe AG, University Hospital Bern |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 1 April 2017 |
| Primary completion | 31 December 2017 |
| Estimated completion | 25 January 2018 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Simulation
Conditions studied
- Pediatric Intensive Care Unit — all drugs for Pediatric Intensive Care Unit →
- Closed Loop Communication — all drugs for Closed Loop Communication →
- In-situ Simulation — all drugs for In-situ Simulation →
- Behavioral Changes — all drugs for Behavioral Changes →
Sponsor
Insel Gruppe AG, University Hospital Bern
Who can join
Adults 20 to 65, any sex, with Pediatric Intensive Care Unit or Closed Loop Communication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Open interventional before and after study on the effect of on-site full-scale simulation with a subsequent course follow-up and a three month follow-up observation pertaining to behavioural changes in communication of the paediatric intensive care unit staff that is participating in the on-site simulation training.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03600298
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Simulation
Trials testing the same drug.
- NCT06738316 — Clinical Experience of Maintaining Patient Safety in Hospital · completed
- NCT06689475 — The Effect of Simulation on Cardiac Auscultation Competence · NA · completed
- NCT06572033 — Transference of Established Simulated Skills (TEST) Trial · active not recruiting
- NCT06265168 — Comprehensive Observations and Multidisciplinary Approaches in the Management of Unconscious Patients · active not recruiting
- NCT05250089 — Physicians Performance After Night Shifts · NA · unknown
Other recruiting trials for Pediatric Intensive Care Unit
Currently open trials in the same condition.
- NCT07128446 — COPM-Based Goal Setting Strategies in the PICU · NA · recruiting
Other Insel Gruppe AG, University Hospital Bern trials
Trials by the same sponsor.
- NCT06546384 — GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease · NA · not yet recruiting
- NCT07524049 — Giving Children a Voice in Paediatric Anaesthesia · not yet recruiting
- NCT07415668 — Motor Eloquent Navigated Transcranial Magnetic Stimulation for Radiosurgery Planning · NA · not yet recruiting
- NCT07478536 — Stockholm3 Test Validation in Men on Active Surveillance in Switzerland (CHAS3 Trial) · not yet recruiting
- NCT07201506 — Real-Time Intracardiac Echocardiography for Ventricular Arrhythmia Ablation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03600298 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Insel Gruppe AG, University Hospital Bern
- Last refreshed: 26 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03600298.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing